Clinicopathologic features, surgical treatments and outcomes of small bowel tumors

Abstract

Introduction: Small bowel tumor is a rare disease, mainly malignant, with diverse clinical morphology. This study aims to describe the clinical, para-clinical morphology, pathology, and early outcomes of surgical treatment for patients with small bowel tumor at Viet Duc University Hospital.

Patients and methods: Descriptive retrospective study, patients with small bowel tumors were operated at Viet Duc University Hospital from January 2015 to December 2020.

Results: 64 patients (mean age 54.12 ± 15.49, 30 men, 34 women) underwent surgery at Viet Duc University Hospital from January 2015 to December 2020. Acute form: 32.1%. Chronic clinical forms: 62.5%. Malignant tumors account for 52/64 cases (81.2%) while GISTs intermediate risk- high risk accounted for 61.5% mainly. The percentage of small bowel resection was 89.1%. There was no other postoperative complication, except one case of postoperative death. The survival time after surgery was 58.82±3.04 months, the best case was GIST 61 months, the worst was Adenocarcinoma 6 months.

Conclusion: Small bowel tumor is a rare disease, mostly malignant at the middle age with silent progression, often detected when the disease at a last stage. GIST accounts for the high proportion (57.8%) with positive treatment results.

Keywords: Small bowel tumor, histopathology, surgical treatment.

References

1. Chang Hyun Kim vaø cs (2010), Clinicopathological Features of Primary Jejunoileal Tumors, J Korean Soc Coloproctol 2010:26(5);334-338.
2. Shao-Liang Han vaø cs: Surgically treated primary malignant tumor of small bowel: A clinical analysis (2010), World Journal Of Gastroenterology 16(12):1527-1532.
3. Shuisheng Zhang vaø cs (2017), Clinicopathologic features, surgical treatments, and outcomes of small bowel tumors: A retrospective study in China, International Journal of Surgery 43 (2017) 145-154.
4. Xing G, Wang S, Sun Y-M, Yuan Z, Zhao X-M, Zhou C. Small Bowel Stromal Tumors: Different Clinicopathologic and Computed Tomography Features in Various Anatomic Sites. PLOS ONE. 2015;10(12):e0144277. doi:10.1371/journal.pone.0144277.
5. Ocasio Quinones GA, Woolf A. Small Bowel Cancer. In: StatPearls. StatPearls Publishing; 2021. Accessed August 30, 2021.
6. The ESMO / European Sarcoma Network Working Group Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology 23 (Supplement 7): vii49–vii55, 2012.
7. Joensuu H. Risk strati?cation of patients diagnosed with gastrointestinal stromal tumour. Hum Pathol 2008; 39: 1411–19.
8. Le Tu Hoang (2021), Small bowel tumor. Gastrointestinal Surgical Pathologies. Medical Publisher,13: 200-219.
9. Chu Duc Quang (2016), Study of clinical, para-clinical and results of surgical treatment of small bowel cancer at Bach Mai Hospital. Thesis of Second Specialized Doctor, Gastrointestinal Surgery. Hanoi Medical University.
10. Nguyen Van Giao (2010), Clinical, para-clinical features and assessment of results of surgical treatment of small bowel cancer at Bach Mai Hospital. Thesis of Second Specialized Doctor, Gastrointestinal Surgery. Hanoi Medical University
11. Kim SJ, Choi CW, Mun Y-C, et al (2011). Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL). BMC Cancer.;11:321. doi:10.1186/1471-2407-11-321.
12. Tevfik Avci vaø cs. Primary small intestinal non-Hodgkin lymphoma diagnosed after emergency surgery. Ulus Travma Acil Cerrahi Derg, March 2017, Vol. 23, No. 2, 129.